Treatment of female sexual dysfunction
March 30, 2020. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent References 3800038 Novel drug delivery device Drug delivery device Device for delivery of useful agent Method of preparing and administering a foam enema 15-Methyl- and 16-phenoxy-PGF2 , amides Topical application of prostaglandin hypotensive agents 9-Fluoroprostaglandin derivatives, and use as medicinal agents Treatment of psychosexual dysfunctions Treatment of sexual dysfunction Inventors
ApplicationNo. 539484 filed on 03/30/2000US Classes:514/149, Azoxy DOAI514/150, Acyclic nitrogen double bonded to acyclic nitrogen, acyclic nitrogen triple bonded to acyclic nitrogen or azide DOAI514/236.5, The ring nitrogens are bonded directly to each other (e.g., pyridazine, etc.)514/236.8, Ring chalcogen in the additional hetero ring (e.g., oxazole, etc.)514/530, Z contains a cyclopentyl or cyclopentene ring514/573Cyclopentyl or cyclopentene (e.g., prostaglandins, etc.)ExaminersPrimary: Criares, Theodore J.Attorney, Agent or FirmForeign Patent References
International ClassesA61K 031/655A61K 031/535 A61K 031/557 A61K 031/19 AbstractMethods and formulations for treating female sexual dysfunction are provided. A pharmaceutical composition formulated so as to contain a selected vasoactive agent is administered to the vagina, vulvar area or urethra of the individual undergoing treatment. Suitable vasoactive agents are vasodilators, including naturally occurring prostaglandins, synthetic prostaglandin derivatives, endothelial-derived relaxation factors, vasoactive intestinal polypeptide agonists, smooth muscle relaxants, leukotriene inhibitors, and others. The formulations are also useful for preventing the occurrence of yeast infections, improving vaginal muscle tone and tissue health, enhancing vaginal lubrication, and minimizing excess collagen deposition. A clitoral drug delivery device is also provided.Other References
Field of SearchAzoxy DOAIAcyclic nitrogen double bonded to acyclic nitrogen, acyclic nitrogen triple bonded to acyclic nitrogen or azide DOAI The ring nitrogens are bonded directly to each other (e.g., pyridazine, etc.) Ring chalcogen in the additional hetero ring (e.g., oxazole, etc.) Cyclopentyl or cyclopentene (e.g., prostaglandins, etc.) | |
